Cme (CME) Return on Sales (2009 - 2026)

Cme (CME) has reported Return on Sales for 18 consecutive years, with 0.01% the latest figure, recorded in Q2 2026.

• Quarterly Return on Sales changed 0.0% year-over-year to 0.01% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.01% (changed 0.0% YoY) and the FY2025 annual result came in at 0.01%, changed 0.0% from the prior year.
• Return on Sales fell to 0.01% in Q2 2026 per CME's latest filing, from 0.01% in the prior quarter.
• Over the last five years, Return on Sales for CME reached as high as 0.01% in Q4 2025 and fell as low as 0.01% in Q1 2022.
• A 5-year average of 0.01% and a median of 0.01% in 2024 frame the typical range for Return on Sales.
• The largest YoY upside for Return on Sales was 0 bps in 2022 against a maximum downside of 0 bps in 2022.
• Year by year, Return on Sales stood at 0.01% in 2022, then increased by 7 bps to 0.01% in 2023, then climbed by 1 bps to 0.01% in 2024, then gained by 25 bps to 0.01% in 2025, then decreased by 15 bps to 0.01% in 2026.
• According to Business Quant data, Return on Sales over the past three periods registered 0.01%, 0.01%, and 0.01% for Q2 2026, Q1 2026, and Q4 2025 respectively.